Mirae Asset Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.39%)Nav, as on 25-02-2025

  • Previous Nav

  • Net Change on 25-02-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Mirae Asset Healthcare Fund -Regular Growth -6.93 -9.14 9.20 17.16 23.60 20.30
BSE Health Care - TRI -6.61 -9.15 10.67 19.98 23.65 15.26
BSE SENSEX - TRI -1.97 -6.74 3.24 11.52 14.50 13.30

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 9.20 17.16 23.60 1.94 2,652.24
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 6.33 18.76 23.68 1.82 8,160.74
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 13.66 22.88 26.21 1.93 4,917.81
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 12.23 22.81 24.70 1.94 3,521.93
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 12.32 20.93 25.06 1.91 3,197.52
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 6.77 18.80 22.38 2.16 1,211.73

Fund Holdings as on 31-January-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Aurobindo Pharma Limited

  • Lupin Limited

  • Divi's Laboratories Limited

  • Glenmark Pharmaceuticals Limited

  • Apollo Hospitals Enterprise Limited

  • Dr. Reddy's Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • Suven Pharmaceuticals Limited

  • Torrent Pharmaceuticals Limited

  • Syngene International Limited

  • Gland Pharma Limited

  • Wockhardt Limited

  • Mankind Pharma Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Alkem Laboratories Limited

  • Sai Life Sciences Limited

  • Fortis Healthcare Limited

  • Onesource Specialty Pharma Limited

  • Aster DM Healthcare Limited

  • IPCA Laboratories Limited

  • Zydus Lifesciences Limited

  • Biocon Limited

  • Alembic Pharmaceuticals Limited

  • Sagility India Limited

  • TREPS

  • Laxmi Dental Limited

  • Neogen Chemicals Limited

  • SRF Limited

  • Suraksha Diagnostic Limited

  • Mirae Asset Liquid Fund - Direct Growth

  • Ajanta Pharma Limited

  • Dr. Lal Path Labs Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Chemicals

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About Mirae Asset Healthcare Fund

Scheme Analysis

Mirae Asset Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Mirae Asset Mutual Fund. It was launched on 02-Jul-2018 and currently has an AUM of ₹2,652.24 crore. Mirae Asset Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of Mirae Asset Healthcare Fund ended down ₹-0.13(-0.39%)yesterday to ₹34.23.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Mirae Asset Healthcare Fund is managed by Vrijesh Kasera .

Fund House Contact

Unit 606, 6th Floor, Windsor Building, Off CST Road, Kalina, Santacruz (E), Mumbai - 400 098

022-67800300
022-67253940